MTAP loss seen in 17% of NSCLC by immunohistochemistry, with PRMT5 inhibitors active in TKI-resistant cells
Read the article

Massachusetts General Hospital, Boston
Dr. Zofia Piotrowska is a thoracic medical oncologist at Massachusetts General Hospital and an instructor in medicine at Harvard Medical School in Boston, USA. Her research focuses on understanding and overcoming resistance to targeted therapies in lung cancer, particularly EGFR-mutant non-small cell lung cancer, and on integrating circulating tumor DNA (ctDNA) diagnostics into clinical care. She co-directs the Mass General Brigham Thoracic Medical Oncology Program, leads multiple early-phase EGFR-targeted clinical trials, and chairs the EGFR Resisters Research Summit. She is a frequent speaker at major international thoracic oncology congresses.
Zofia Piotrowska
Programme Roster